$0.4950
-0.0037-0.74%
At close: Dec 15, 4:00 PM EST
$0.5000
0.0051.01%
After Hours: 7:12 PM EST
Comments
Loading...
Adicet Bio Insider Trading Activity | NASDAQ:ACET | Benzinga
Track the latest Adicet Bio insider trading activity. Stay informed on recent buys, sells, and market impact for Adicet Bio stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Adicet Bio Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On October 10, 2025, ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II LP, OrbiMed Israel GP Ltd, OrbiMed Israel BioFund GP Limited Partnership, the company's 10% OWNER purchased 5M shares for $1 each.
Ownership Statistics for Adicet Bio Inc
Shares Outstanding
153.256M
Insider Shares Owned
663.926K
Insider Percentage Owned
0.43%
Institutional Shares Held
16.957M
Institutional Percentage Held
11.1%
| Oct 10, 2025 | ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Capital GP VI LLCOrbiMed Genesis GP LLCOrbiMed Advisors Israel II LtdOrbiMed Israel GP II LPOrbiMed Israel GP LtdOrbiMed Israel BioFund GP Limited Partnership | 10% OWNER | 5.00M | $1.00 | $5.00M | BUY | 670.03% | 5.75M | Oct 08 | View |
| Jun 07, 2024 | Michael Kauffman | — | 0.00 | $1.43 | -$8.44K | GRANT | 0.00% | 5.90K | Jun 05 | View |
| Jan 26, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Capital GP VI LLCOrbiMed Genesis GP LLCOrbiMed Advisors Israel II LtdOrbiMed Israel GP II LPOrbiMed Israel GP LtdOrbiMed Israel BioFund GP Limited Partnership | — | 3.13M | $2.40 | $7.50M | BUY | ∞ | 1.90M | Jan 25 | View |
| Jan 26, 2024 | Carl L Gordon | — | 3.13M | $2.40 | $7.50M | BUY | ∞ | 1.90M | Jan 25 | View |
| Oct 02, 2023 | Chen Schor | PRESIDENT & CEO | -23.21K | $1.38 | -$31.94K | SELL | -10.07% | 207.19K | Sep 28 - Oct 02 | View |
| Jun 30, 2023 | STEVE DUBIN | DIRECTOR | 5.00K | $2.40 | $12.00K | BUY | 84.75% | 10.90K | Jun 30 | View |
| Jun 29, 2023 | Carl L Gordon | DIRECTOR | 875.00K | $2.09 | $1.83M | BUY | 1001.84% | 962.34K | Jun 27 | View |
| Jun 29, 2023 | ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Capital GP VI LLCOrbiMed Genesis GP LLCOrbiMed Advisors Israel II LtdOrbiMed Israel GP II LPOrbiMed Israel GP LtdOrbiMed Israel BioFund GP Limited PartnershipErez Chimovits | DIRECTOR | 875.00K | $2.09 | $1.83M | BUY | 1001.84% | 962.34K | Jun 27 | View |
| Feb 17, 2023 | Don Healey | CHIEF TECHNOLOGY OFFICER | -4.53K | $7.57 | -$34.33K | SELL | -6.38% | 66.57K | Feb 15 | View |
| Feb 14, 2023 | Don Healey | CHIEF TECHNOLOGY OFFICER | -10.47K | $7.98 | -$83.48K | SELL | -12.83% | 71.10K | Feb 10 | View |
| Nov 15, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -6.97K | $21.00 | -$146.31K | SELL | -19.81% | 28.21K | Nov 10 | View |
| Nov 15, 2022 | Chen Schor | PRESIDENT & CEO | -39.95K | $20.30 | -$811.24K | SELL | -42.79% | 53.42K | Nov 10 | View |
| Nov 09, 2022 | Chen Schor | PRESIDENT & CEO | -30.00K | $19.05 | -$571.49K | SELL | -13.96% | 184.85K | Nov 07 | View |
| Nov 04, 2022 | Chen Schor | PRESIDENT & CEO | -25.31K | $18.04 | -$456.72K | SELL | -10.54% | 214.85K | Nov 02 - Nov 03 | View |
| Oct 21, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -8.07K | $16.27 | -$131.25K | SELL | -18.66% | 35.18K | Oct 19 | View |
| Oct 14, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -6.19K | $11.61 | -$126.64K | SELL | -12.52% | 43.24K | Oct 12 - Oct 13 | View |
| Sep 16, 2022 | Chen Schor | PRESIDENT & CEO | -952.00 | $18.00 | -$17.14K | SELL | -0.36% | 261.45K | Sep 14 | View |
| Sep 13, 2022 | Chen Schor | PRESIDENT & CEO | -78.41K | $16.80 | -$1.32M | SELL | -23.01% | 262.40K | Sep 09 - Sep 13 | View |
| Aug 05, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -6.97K | $18.00 | -$125.42K | SELL | -15.17% | 38.97K | Aug 03 | View |
| Aug 03, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -6.97K | $16.64 | -$115.95K | SELL | -13.17% | 45.94K | Aug 01 | View |
| Jul 07, 2022 | Blake Aftab | CHIEF SCIENTIFIC OFFICER | -1.36K | $14.50 | -$19.76K | SELL | -2.51% | 52.90K | Jul 05 | View |
| Apr 05, 2022 | Francesco Galimi | SVP & CHIEF MEDICAL OFFICER | 0.00 | $15.51 | -$171.15K | SELL-OPTIONS | 0.00% | 59.92K | Apr 01 - Apr 04 | View |
| Mar 11, 2022 | Aya Jakobovits | DIRECTOR | -4.00K | $14.00 | -$56.00K | SELL | -0.80% | 494.42K | Mar 09 | View |
| Feb 17, 2022 | Aya Jakobovits | DIRECTOR | -4.00K | $14.83 | -$59.33K | SELL | -0.80% | 496.42K | Feb 16 | View |
| Feb 14, 2022 | Aya Jakobovits | DIRECTOR | -24.00K | $16.51 | -$396.16K | SELL | -4.59% | 498.42K | Jan 03 - Feb 09 | View |
| Dec 10, 2021 | Andrew Sinclair | DIRECTOR | 500.00K | $14.00 | $7.00M | BUY | 30.47% | 2.14M | Dec 08 | View |
| Jun 21, 2021 | Chen Schor | PRESIDENT & CEO | -16.47K | $10.53 | -$173.44K | SELL | -15.49% | 89.84K | Jun 16 | View |
| Jun 17, 2021 | Aya Jakobovits | DIRECTOR | -3.85K | $11.16 | -$42.92K | SELL | -1.08% | 351.68K | Jun 15 | View |
| Jun 07, 2021 | Chen Schor | PRESIDENT & CEO | -16.47K | $12.06 | -$198.50K | SELL | -14.28% | 98.82K | Jun 03 | View |
| May 21, 2021 | Chen Schor | PRESIDENT & CEO | -16.47K | $13.45 | -$221.44K | SELL | -13.25% | 107.80K | May 19 | View |
| May 20, 2021 | Aya Jakobovits | DIRECTOR | -8.00K | $14.09 | -$112.75K | SELL | -2.21% | 353.61K | May 18 - May 20 | View |
| May 14, 2021 | Aya Jakobovits | DIRECTOR | -10.00K | $13.23 | -$132.33K | SELL | -2.72% | 357.61K | May 12 | View |
| May 07, 2021 | Chen Schor | PRESIDENT & CEO | -16.47K | $14.22 | -$234.22K | SELL | -12.36% | 116.78K | May 05 | View |
| Apr 22, 2021 | Chen Schor | PRESIDENT AND CEO | -16.47K | $12.01 | -$197.68K | SELL | -13.58% | 104.78K | Apr 20 | View |
| Apr 08, 2021 | Chen Schor | PRESIDENT AND CEO | -16.47K | $13.04 | -$214.70K | SELL | -12.79% | 112.26K | Apr 06 | View |
| Apr 01, 2021 | Chen Schor | PRESIDENT AND CEO | -16.47K | $12.85 | -$211.64K | SELL | -12.09% | 119.75K | Mar 30 | View |
| Mar 18, 2021 | Chen Schor | PRESIDENT AND CEO | -16.47K | $15.34 | -$252.56K | SELL | -11.46% | 127.23K | Mar 16 | View |
| Feb 27, 2019 | Frank DeBenedittis | SR. VICE PRESIDENT | -47.13K | $0.21 | -$10.11K | SELL | -51.45% | 44.47K | Feb 26 | View |
| Dec 26, 2018 | Frances Scally | SVP, CHIEF ACCOUNTING OFFICER | -183.00 | $0.91 | -$166.97 | SELL | -1.07% | 16.92K | Dec 26 | View |
| Oct 05, 2018 | Steven Rogers | SVP, CHIEF LEGAL OFFICER | 969.00 | $2.32 | $2.27K | GRANT | 2.89% | 34.50K | Oct 04 | View |
| Oct 05, 2018 | Albert Eilender | CHAIRMAN | 2.64K | $2.32 | $6.21K | GRANT | 0.90% | 297.31K | Oct 04 | View |
| Oct 05, 2018 | Frank DeBenedittis | SR. VICE PRESIDENT | 1.02K | $2.31 | $2.43K | GRANT | 1.13% | 91.60K | Oct 04 - Oct 05 | View |
| Oct 05, 2018 | Charles J. Alaimo | SENIOR VICE PRESIDENT | 883.00 | $2.35 | $2.03K | GRANT | 4.26% | 21.59K | Oct 04 | View |
| Sep 07, 2018 | Steven Rogers | SVP, CHIEF LEGAL OFFICER | -3.77K | $3.33 | -$12.56K | SELL | -10.10% | 33.53K | Sep 07 | View |
| Sep 07, 2018 | Walter Kaczmarek | CHIEF OPERATING OFFICER | -6.40K | $3.33 | -$21.30K | SELL | -10.13% | 56.78K | Sep 07 | View |
| Sep 07, 2018 | Albert Eilender | CHAIRMAN | -10.70K | $3.29 | -$35.22K | SELL | -3.50% | 294.67K | Sep 07 | View |
| Sep 07, 2018 | Frank DeBenedittis | SR. VICE PRESIDENT | -2.80K | $3.33 | -$9.31K | SELL | -3.00% | 90.58K | Sep 07 | View |
| Sep 07, 2018 | Frances Scally | SVP, CHIEF ACCOUNTING OFFICER | -789.00 | $3.29 | -$2.60K | SELL | -4.41% | 17.10K | Sep 05 | View |
| Sep 07, 2018 | Charles J Alaimo | SENIOR VICE PRESIDENT | -3.46K | $3.29 | -$11.38K | SELL | -14.31% | 20.70K | Sep 05 | View |
| Aug 06, 2018 | Walter J. Kaczmarek III | CHIEF OPERATING OFFICER | -7.00K | $3.18 | -$22.29K | SELL | -9.97% | 63.18K | Aug 03 | View |
| Jul 06, 2018 | Charles J. Alaimo | SENIOR VICE PRESIDENT | -1.46K | $3.36 | -$4.89K | SELL | -5.69% | 24.16K | Jul 03 | View |
| Jul 06, 2018 | Frances Scally | SVP, CHIEF ACCOUNTING OFFICER | -601.00 | $3.36 | -$2.02K | SELL | -3.25% | 17.89K | Jul 03 | View |
| Jul 06, 2018 | Steven Rogers | SVP, CHIEF LEGAL OFFICER | -1.23K | $3.69 | -$4.54K | SELL | -3.19% | 37.30K | Jul 05 | View |
| Jul 06, 2018 | Frank DeBenedittis | SR. VICE PRESIDENT | -1.17K | $3.69 | -$4.32K | SELL | -1.24% | 93.38K | Jul 05 | View |
| Jul 06, 2018 | Albert Eilender | CHAIRMAN | -3.80K | $3.68 | -$13.99K | SELL | -1.23% | 305.37K | Jul 05 | View |
| Jan 12, 2018 | /S/ Frances Scally | SVP, CHIEF ACCOUNTING OFFICER | -309.00 | $10.44 | -$3.23K | SELL | -1.64% | 18.49K | Dec 26 | View |
| Sep 08, 2017 | Steven Rogers | SVP, CHIEF LEGAL OFFICER | -2.00K | $10.34 | -$20.69K | SELL | -4.93% | 38.53K | Sep 08 | View |
| Sep 07, 2017 | Douglas Roth | SR. VICE PRESIDENT & CFO | 108.00 | $10.49 | $1.14K | GRANT | 0.10% | 105.69K | Sep 05 - Sep 07 | View |
| Sep 07, 2017 | Salvatore Guccione | PRESIDENT AND CEO | 298.00 | $10.49 | $3.13K | GRANT | 0.12% | 245.05K | Sep 05 - Sep 07 | View |
| Sep 06, 2017 | Frank DeBenedittis | SR. VICE PRESIDENT | 17.61K | $10.57 | $188.48K | GRANT | 22.89% | 94.55K | Sep 01 - Sep 06 | View |
| Sep 06, 2017 | Douglas Roth | SR. VICE PRESIDENT & CFO | 31.18K | $10.57 | $334.03K | GRANT | 41.91% | 105.59K | Sep 01 - Sep 06 | View |
| Sep 06, 2017 | Steve Rogers | SVP, CHIEF LEGAL OFFICER | 21.54K | $10.57 | $230.20K | GRANT | 113.37% | 40.53K | Sep 01 - Sep 06 | View |
| Sep 06, 2017 | Albert Eilender | CHAIRMAN | 50.94K | $10.57 | $545.51K | GRANT | 19.73% | 309.17K | Sep 01 - Sep 06 | View |
| Sep 06, 2017 | Salvatore Guccione | PRESIDENT AND CEO | 54.09K | $10.57 | $579.15K | GRANT | 28.37% | 244.75K | Sep 01 - Sep 06 | View |
| Sep 06, 2017 | Charles J. Alaimo | SENIOR VICE PRESIDENT | 10.60K | $10.60 | $113.85K | GRANT | 70.61% | 25.62K | Sep 01 - Sep 06 | View |
| Sep 05, 2017 | Walter Kaczmarek | CHIEF OPERATING OFFICER | 22.27K | $10.62 | $237.83K | GRANT | 46.47% | 70.18K | Sep 01 - Sep 05 | View |
| Aug 03, 2017 | Walter J. Kaczmarek III | CHIEF OPERATING OFFICER | -7.08K | $16.57 | -$117.35K | SELL | -12.88% | 47.92K | Aug 02 | View |
| Jul 07, 2017 | Steven Rogers | SVP, CHIEF LEGAL OFFICER | -2.29K | $15.45 | -$35.30K | SELL | -10.74% | 19.00K | Jul 05 | View |
| Jul 07, 2017 | Douglas Roth | SR. VICE PRESIDENT & CFO | -5.08K | $15.47 | -$78.52K | SELL | -6.39% | 74.40K | Jul 05 | View |
| Jul 07, 2017 | Charles J. Alaimo | SENIOR VICE PRESIDENT | -2.61K | $15.48 | -$40.43K | SELL | -14.82% | 15.02K | Jul 05 | View |
| Jul 07, 2017 | Frank DeBenedittis | SR. VICE PRESIDENT | -2.09K | $15.28 | -$31.93K | SELL | -2.64% | 76.94K | Jul 06 | View |
| Jul 07, 2017 | Albert Eilender | CHAIRMAN | -6.50K | $15.21 | -$98.87K | SELL | -2.51% | 252.03K | Jul 06 | View |
| Jul 07, 2017 | Salvatore Guccione | PRESIDENT AND CEO | -7.42K | $15.21 | -$112.88K | SELL | -3.75% | 190.66K | Jul 06 | View |
| Mar 10, 2017 | Frank DeBenedittis | SR. VICE PRESIDENT | 1.40K | $11.49 | -$13.52K | SELL-OPTIONS | 1.80% | 79.03K | Mar 09 | View |
| Mar 09, 2017 | Charles J. Alaimo | SENIOR VICE PRESIDENT | -1.50K | $15.03 | -$22.54K | SELL | -7.84% | 17.63K | Mar 07 | View |
| Mar 09, 2017 | Charles J. Alaimo | SENIOR VICE PRESIDENT | -4.00K | $20.34 | -$81.36K | SELL | -17.29% | 19.13K | Dec 01 | View |
| Jan 18, 2017 | Daniel Yarosh | DIRECTOR | -891.00 | $20.69 | -$18.43K | SELL | -9.82% | 8.18K | Jan 17 | View |
| Dec 09, 2016 | Terry Kippley | SR. VICE PRESIDENT | -3.00K | $21.22 | -$63.67K | SELL | -12.83% | 20.38K | Dec 08 - Dec 09 | View |
| Dec 09, 2016 | Douglas Roth | SR. VICE PRESIDENT & CFO | -5.00K | $21.03 | -$105.16K | SELL | -5.92% | 79.48K | Dec 08 | View |
| Dec 09, 2016 | Raymond Bartone | SENIOR VICE PRESIDENT | -5.00K | $21.54 | -$107.70K | SELL | -13.00% | 33.45K | Dec 09 | View |
| Dec 08, 2016 | Nicholas Shackley | SENIOR VICE PRESIDENT | -2.50K | $21.27 | -$53.17K | SELL | -7.36% | 31.48K | Dec 08 | View |
| Dec 01, 2016 | Terry Kippley | SR. VICE PRESIDENT | -2.00K | $20.34 | -$40.68K | SELL | -7.88% | 23.38K | Nov 29 - Nov 30 | View |
| Nov 30, 2016 | Satish Srinivasan | PRESIDENT & COO - RISING PHARM | -12.92K | $20.02 | -$258.53K | SELL | -38.73% | 20.43K | Nov 29 | View |
| Nov 30, 2016 | Frank DeBenedittis | SR. VICE PRESIDENT | -7.04K | $20.22 | -$142.38K | SELL | -8.32% | 77.63K | Nov 29 - Nov 30 | View |
| Nov 23, 2016 | Steven Rogers | SVP, CHIEF LEGAL OFFICER | -2.40K | $19.53 | -$46.88K | SELL | -10.14% | 21.28K | Nov 23 | View |
| Nov 15, 2016 | Hans Noetzli | DIRECTOR | 199.00 | $13.18 | -$60.00K | SELL-OPTIONS | 0.25% | 79.57K | Nov 14 | View |
| Nov 15, 2016 | William Britton | DIRECTOR | 0.00 | $13.25 | -$49.79K | SELL-OPTIONS | 0.00% | 40.57K | Nov 14 | View |
| Sep 08, 2016 | Salvatore Guccione | PRESIDENT AND CEO | 368.00 | $19.70 | $7.31K | GRANT | 0.19% | 198.08K | Sep 06 - Sep 08 | View |
| Sep 08, 2016 | Douglas Roth | SR. VICE PRESIDENT & CFO | 161.00 | $19.75 | $3.19K | GRANT | 0.19% | 84.48K | Sep 06 - Sep 08 | View |
| Sep 08, 2016 | Charles J. Alaimo | SENIOR VICE PRESIDENT | 37.00 | $19.60 | $739.99 | GRANT | 0.16% | 23.13K | Sep 06 - Sep 07 | View |
| Sep 06, 2016 | Salvatore Guccione | CHIEF EXECUTIVE OFFICER | 52.14K | $19.92 | $1.05M | GRANT | 35.81% | 197.72K | Sep 01 - Sep 06 | View |
| Sep 06, 2016 | Douglas Roth | SR. VICE PRESIDENT & CFO | 24.83K | $19.94 | $499.06K | GRANT | 41.73% | 84.32K | Sep 01 - Sep 06 | View |
| Sep 06, 2016 | Frank DeBenedittis | SENIOR VICE PRESIDENT | 17.17K | $19.94 | $344.73K | GRANT | 25.44% | 84.67K | Sep 01 - Sep 06 | View |
| Sep 06, 2016 | Steven Rogers | SVP, CHIEF LEGAL OFFICER | 11.74K | $20.03 | $235.08K | GRANT | 98.28% | 23.68K | Sep 01 - Sep 06 | View |
| Sep 06, 2016 | Albert Eilender | CHAIRMAN | 43.78K | $19.97 | $878.38K | GRANT | 20.83% | 253.98K | Sep 01 - Sep 06 | View |
| Sep 06, 2016 | Satish Srinivasan | PRESIDENT & COO - RISING PHARM | 17.83K | $19.93 | $357.91K | GRANT | 114.88% | 33.35K | Sep 01 - Sep 06 | View |
| Sep 06, 2016 | Nicholas Shackley | SENIOR VICE PRESIDENT | 13.26K | $19.94 | $266.55K | GRANT | 64.02% | 33.98K | Sep 01 - Sep 02 | View |
| Sep 06, 2016 | Terry Kippley | SR. VICE PRESIDENT | 8.28K | $19.94 | $166.13K | GRANT | 48.43% | 25.38K | Sep 01 - Sep 02 | View |
| Sep 06, 2016 | Raymond Bartone | SENIOR VICE PRESIDENT | 8.73K | $19.94 | $175.25K | GRANT | 29.39% | 38.45K | Sep 01 - Sep 02 | View |
| Sep 06, 2016 | Charles J. Alaimo | SENIOR VICE PRESIDENT | 11.34K | $19.94 | $227.54K | GRANT | 96.44% | 23.09K | Sep 01 - Sep 02 | View |
| Jul 07, 2016 | Frank DeBenedittis | SR. VICE PRESIDENT | -3.27K | $23.34 | -$76.43K | SELL | -4.63% | 67.50K | Jul 07 | View |
| Jul 07, 2016 | Nicholas Shackley | SR. VICE PRESIDENT | -3.56K | $22.41 | -$79.87K | SELL | -14.68% | 20.71K | Jul 06 | View |
| Jul 07, 2016 | Raymond Bartone | SENIOR VICE PRESIDENT | -2.39K | $22.41 | -$53.61K | SELL | -7.45% | 29.72K | Jul 06 | View |
| Jul 07, 2016 | Satish Srinivasan | PRESIDENT & COO - RISING PHARM | -3.25K | $22.80 | -$74.10K | SELL | -16.78% | 16.12K | Jul 06 | View |
| Jul 07, 2016 | Steven Rogers | S.V.P. & CHIEF LEGAL OFFICER | -3.27K | $22.50 | -$73.68K | SELL | -21.52% | 11.94K | Jul 06 | View |
| Jul 07, 2016 | Douglas Roth | SR. VICE PRESIDENT & CFO | -6.77K | $22.72 | -$153.79K | SELL | -10.33% | 58.78K | Jul 06 | View |
| Jul 07, 2016 | Albert Eilender | CHAIRMAN | -7.69K | $22.53 | -$173.22K | SELL | -3.53% | 210.20K | Jul 06 | View |
| Jun 08, 2016 | WILLIAM BRITTON | DIRECTOR | 0.00 | $15.73 | -$62.03K | SELL-OPTIONS | 0.00% | 40.57K | Jun 07 | View |
| May 27, 2016 | Douglas Roth | SR. VICE PRESIDENT & CFO | -7.00K | $22.16 | -$155.12K | SELL | -9.65% | 65.55K | May 26 | View |
| Mar 14, 2016 | Raymond Bartone | SENIOR VICE PRESIDENT | -3.00K | $22.40 | -$67.19K | SELL | -8.54% | 32.11K | Mar 10 | View |
| Mar 08, 2016 | Hans Noetzli | DIRECTOR | 2.78K | $15.63 | -$71.44K | SELL-OPTIONS | 3.63% | 79.37K | Mar 08 | View |
| Mar 04, 2016 | Frank DeBenedittis | SR. VICE PRESIDENT | -3.00K | $21.98 | -$65.93K | SELL | -3.72% | 77.58K | Mar 02 | View |
| Mar 01, 2016 | Steven Rogers | S.V.P. & GENERAL COUNSEL | -2.10K | $21.82 | -$45.82K | SELL | -12.13% | 15.22K | Mar 01 | View |
| Feb 25, 2016 | Albert Eilender | CHAIRMAN | 0.00 | $15.07 | -$124.71K | SELL-OPTIONS | 0.00% | 227.77K | Feb 25 | View |
| Feb 25, 2016 | Douglas Roth | SR. VICE PRESIDENT & CFO | -7.00K | $14.93 | -$282.48K | SELL | -8.80% | 72.55K | Feb 23 | View |
| Feb 25, 2016 | Charles J. Alaimo | SENIOR VICE PRESIDENT | -3.25K | $14.04 | -$94.78K | SELL | -17.43% | 15.39K | Feb 23 | View |
| Dec 10, 2015 | Satish Srinivasan | PRESIDENT & COO - RISING PHARM | -3.00K | $27.02 | -$81.05K | SELL | -11.60% | 22.86K | Dec 09 | View |
| Dec 10, 2015 | Terry Kippley | SR. VICE PRESIDENT | -1.55K | $27.06 | -$41.95K | SELL | -6.80% | 21.25K | Dec 09 | View |
| Dec 08, 2015 | Nicholas Shackley | SENIOR VICE PRESIDENT | -3.00K | $26.70 | -$80.10K | SELL | -11.00% | 24.28K | Dec 08 | View |
| Dec 02, 2015 | Frank DeBenedittis | SR. VICE PRESIDENT | -3.00K | $28.18 | -$84.55K | SELL | -3.59% | 80.58K | Dec 01 | View |
| Dec 02, 2015 | Charles J. Alaimo | SENIOR VICE PRESIDENT | -3.00K | $28.22 | -$84.65K | SELL | -13.86% | 18.64K | Dec 01 | View |
| Nov 25, 2015 | Hans Noetzli | DIRECTOR | 10.00K | $17.17 | $6.09K | SELL-OPTIONS | 15.65% | 73.88K | Nov 25 | View |
| Nov 25, 2015 | Steven Rogers | S.V.P. & GENERAL COUNSEL | -3.00K | $27.56 | -$82.69K | SELL | -14.77% | 17.32K | Nov 24 | View |
| Oct 16, 2015 | Albert Eilender | CHAIRMAN | 4.84K | $17.86 | -$146.99K | SELL-OPTIONS | 2.17% | 227.77K | Oct 15 | View |
| Sep 15, 2015 | DOUGLAS ROTH | SR. VICE PRESIDENT & CFO | 307.00 | $27.12 | $8.38K | GRANT | 0.39% | 79.55K | Sep 14 - Sep 15 | View |
| Sep 15, 2015 | SALVATORE GUCCIONE | PRESIDENT AND CEO | 275.00 | $27.12 | $7.49K | GRANT | 0.18% | 154.99K | Sep 14 - Sep 15 | View |
| Sep 15, 2015 | Charles J. Alaimo | SENIOR VICE PRESIDENT | 84.00 | $27.12 | $2.29K | GRANT | 0.39% | 21.64K | Sep 14 - Sep 15 | View |
| Sep 11, 2015 | N. SHACKLEY | SENIOR VICE PRESIDENT | 5.06K | $22.92 | $124.95K | ACQUISITION | 22.80% | 27.28K | Sep 09 - Sep 10 | View |
| Sep 11, 2015 | Douglas Roth | SR. VICE PRESIDENT & CFO | 5.33K | $22.92 | $135.87K | GRANT | 7.21% | 79.25K | Sep 09 - Sep 10 | View |
| Sep 11, 2015 | TERRY KIPPLEY | SR. VICE PRESIDENT | 2.02K | $22.92 | $49.76K | GRANT | 9.70% | 22.80K | Sep 09 - Sep 10 | View |
| Sep 11, 2015 | Salvatore Guccione | PRESIDENT AND CEO | 11.29K | $22.92 | $281.92K | GRANT | 7.87% | 154.71K | Sep 09 - Sep 10 | View |
| Sep 11, 2015 | STEVEN ROGERS | S.V.P. & GENERAL COUNSEL | 1.90K | $22.92 | $47.09K | GRANT | 10.29% | 20.32K | Sep 09 - Sep 10 | View |
| Sep 11, 2015 | FRANK DEBENEDITTIS | SR. VICE PRESIDENT | 4.06K | $22.92 | $100.17K | GRANT | 5.11% | 83.58K | Sep 09 - Sep 10 | View |
| Sep 11, 2015 | Raymond Bartone | SENIOR VICE PRESIDENT | 2.55K | $22.92 | $62.94K | GRANT | 7.84% | 35.11K | Sep 09 - Sep 10 | View |
| Sep 11, 2015 | Charles J. Alaimo | SENIOR VICE PRESIDENT | 1.69K | $22.92 | $42.50K | GRANT | 8.49% | 21.56K | Sep 09 - Sep 10 | View |
| Jul 28, 2015 | Albert Eilender | CHAIRMAN | -2.45K | $23.62 | -$57.87K | SELL | -1.22% | 198.12K | Jul 27 | View |
| Jul 16, 2015 | Satish Srinivasan | PRESIDENT & COO - RISING PHARM | -545.00 | $26.10 | -$14.22K | SELL | -2.06% | 25.86K | Jul 15 | View |
| Jul 06, 2015 | Satish Srinivasan | PRESIDENT & COO - RISING PHARM | 9.08K | $24.19 | $219.62K | GRANT | 52.27% | 26.45K | Jul 02 | View |
| Jul 06, 2015 | Nicholas Shackley | SR. VICE PRESIDENT | 4.97K | $24.19 | $120.18K | GRANT | 28.72% | 22.27K | Jul 02 | View |
| Jul 06, 2015 | Steven Rogers | SENIOR V.P. & GENERAL COUNSEL | 5.85K | $24.19 | $141.49K | GRANT | 46.30% | 18.48K | Jul 02 | View |
| Jul 06, 2015 | Douglas Roth | SR. VICE PRESIDENT & CFO | 9.25K | $24.19 | $223.81K | GRANT | 14.47% | 73.19K | Jul 02 | View |
| Jul 06, 2015 | Carlos Restrepo | SR. VICE PRESIDENT | 7.08K | $24.19 | $171.34K | GRANT | 88.54% | 15.08K | Jul 02 | View |
| Jul 06, 2015 | Terry Kippley | SR. VICE PRESIDENT | 4.17K | $24.19 | $100.82K | GRANT | 25.03% | 20.82K | Jul 02 | View |
| Jul 06, 2015 | Salvatore Guccione | CHIEF EXECUTIVE OFFICER | 18.39K | $24.19 | $444.76K | GRANT | 14.89% | 141.85K | Jul 02 | View |
| Jul 06, 2015 | Frank DeBenedittis | SR. VICE PRESIDENT | 6.87K | $24.19 | $166.21K | GRANT | 9.45% | 79.57K | Jul 02 | View |
| Jul 06, 2015 | RAYMOND BARTONE | SENIOR VICE PRESIDENT | 3.79K | $24.19 | $91.80K | GRANT | 13.17% | 32.60K | Jul 02 | View |
| Jul 06, 2015 | Charles J. Alaimo | SENIOR VICE PRESIDENT | 5.50K | $24.19 | $133.09K | GRANT | 38.12% | 19.94K | Jul 02 | View |
| Jul 06, 2015 | Albert Eilender | CHAIRMAN | 12.06K | $24.20 | $291.65K | GRANT | 6.40% | 200.57K | Jul 01 - Jul 02 | View |
| Jun 10, 2015 | RAYMOND BARTONE | SENIOR VICE PRESIDENT | -5.00K | $24.44 | -$122.20K | SELL | -14.79% | 28.81K | Jun 08 | View |
| Jun 04, 2015 | Frank DeBenedittis | SR. VICE PRESIDENT | -4.00K | $24.41 | -$97.63K | SELL | -5.21% | 72.70K | Jun 03 | View |
| May 28, 2015 | Charles J. Alaimo | SENIOR VICE PRESIDENT | -2.00K | $23.19 | -$46.38K | SELL | -12.17% | 14.44K | May 27 | View |
| May 26, 2015 | Douglas Roth | SR. VICE PRESIDENT & CFO | -7.00K | $23.82 | -$166.71K | SELL | -9.87% | 63.94K | May 21 | View |
| May 12, 2015 | WILLIAM BRITTON | DIRECTOR | 0.00 | $14.07 | -$188.39K | SELL-OPTIONS | 0.00% | 39.36K | May 12 | View |
| Mar 05, 2015 | Natasha Giordano | DIRECTOR | -2.16K | $20.92 | -$45.28K | SELL | -21.17% | 8.06K | Mar 04 | View |
| Mar 05, 2015 | Douglas Roth | SR. VICE PRESIDENT & CFO | -5.00K | $20.99 | -$104.95K | SELL | -6.58% | 70.94K | Mar 04 | View |
| Feb 17, 2015 | Douglas Roth | SR. VICE PRESIDENT & CFO | -6.00K | $19.91 | -$119.46K | SELL | -7.32% | 75.94K | Feb 12 | View |
| Feb 12, 2015 | Charles J. Alaimo | SENIOR VICE PRESIDENT | -2.00K | $20.15 | -$40.30K | SELL | -10.85% | 16.43K | Feb 10 | View |
FAQ
Q
Is insider trading legal?
A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q
What are some examples of market manipulation?
A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
ACET Insider Trading News
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved